ArticlemedRxiv : the preprint server for health sciences2023

Thyroid hyperplasia and neoplasm adverse events associated with GLP-1 receptor agonists in FDA Adverse Event Reporting System.

Tigran Makunts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.